Impact of elexacaftor-tezacaftor-ivacaftor in lung transplantation for cystic fibrosis in the United States

Background: Cystic fibrosis (CF) is an autosomal recessive condition leading to progressive lung disease and often necessitating lung transplantation. Historically, CF has been one of the leading indications for lung transplants in the United States. The advent of CF transmembrane conductance regula...

Full description

Bibliographic Details

Published in:	JHLT Open
Main Authors:	Tahuanty A. Pena, MD, MS, Brittany Wright, PharmD, Kalpaj R. Parekh, MBBS, Julia Kleney-Tait, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Subjects:	elexacaftor tezacaftor ivacaftor cystic fibrosis lung transplant
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950133424001204